SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹374 Cr | ₹265 Cr | ₹179 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹374 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹179 Cr |
How is Total Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹374 Cr | 41.19 | |
| Mar2024 | ₹265 Cr | 48.12 | |
| Mar2023 | ₹179 Cr | - | |
Compare Total Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,619.8 Cr | -4% | 22.3% | 27% | Stock Analytics | |
| SAGILITY | ₹18,369.5 Cr | -2% | -8.9% | 2.8% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹18,080.3 Cr | 3.2% | -6.4% | -29.7% | Stock Analytics | |
| PRIME FOCUS | ₹17,580.1 Cr | -5.6% | -21.6% | 95.5% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,298.5 Cr | -4.1% | 7.2% | -11.7% | Stock Analytics | |
| INDEGENE | ₹12,234.2 Cr | -2.9% | -3.8% | -12.9% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -4% |
22.3% |
27% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses